{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/65219-120#drug","name":"DALBAVANCIN HYDROCHLORIDE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"65219-120"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA217591"},{"@type":"PropertyValue","propertyID":"UNII","value":"33WDQ7T81E"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"2c2ec45e-48a2-4887-8ab0-9244eb39a394"}],"activeIngredient":"DALBAVANCIN HYDROCHLORIDE","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Fresenius Kabi USA, LLC"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA217591","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c2ec45e-48a2-4887-8ab0-9244eb39a394","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-120"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T15:23:12.535Z"}}